Showing results (691-700 of 788) with videos related to

Sort By:
Pageof 79
Hypertension (Dallas, Tex. : 1979)|October 29, 2014
High-sensitivity troponin T and cardiovascular events in systolic blood pressure categories: atherosclerosis risk in communities studyYashashwi Pokharel, Wensheng Sun, James A de Lemos, et al.
Journal of the American Heart Association|May 2, 2022
Obesity, Galectin-3, and Incident Heart Failure: The ARIC StudyRoberta Florido, Lucia Kwak, Justin B Echouffo-Tcheugui, et al.
Journal of Inherited Metabolic Disease|April 12, 2021
A generic emergency protocol for patients with inborn errors of metabolism causing fasting intolerance: A retrospective, single-center study and the generation of www.emergencyprotocol.netAlessandro Rossi, Irene J Hoogeveen, Charlotte M A Lubout, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 14, 2023
Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-upEsther N M de Rooij, Johan W de Fijter, Saskia Le Cessie, et al.
Diagnostic and Prognostic Research|June 23, 2020
The impact of the Trauma Triage App on pre-hospital trauma triage: design and protocol of the stepped-wedge, cluster-randomized TESLA trialRogier van der Sluijs, Audrey A A Fiddelers, Job F Waalwijk, et al.
Atherosclerosis|November 26, 2013
The Effect of Lipid Modification on Peripheral Artery Disease after Endovascular Intervention Trial (ELIMIT)Gerd Brunner, Eric Y Yang, Anirudh Kumar, et al.
Human Molecular Genetics|March 5, 2002
Knockout mouse model for Fxr2: a model for mental retardationCarola J M Bontekoe, Kellie L McIlwain, Ingeborg M Nieuwenhuizen, et al.
European Heart Journal|March 23, 2017
PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemiaSophie J Bernelot Moens, Annette E Neele, Jeffrey Kroon, et al.
European Heart Journal|August 19, 2020
Improved cardiovascular risk prediction using targeted plasma proteomics in primary preventionRenate M Hoogeveen, João P Belo Pereira, Nick S Nurmohamed, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 24, 2025
Can Alpha-Glucosidase Activity in Plasma or Leukocytes Serve as a Biomarker for Future Gene Therapy in Classic Infantile Pompe Disease?Martha C Faraguna, Daniël A M Lambregts, Ina Barzel, et al.
Pageof 79